Editorial | Published:

Rationalizing combination therapies

Nature Medicine volume 23, page 1113 (2017) | Download Citation

A growing number of clinical trials on combination therapies raises the question of to what degree they may be redundant. Systems biology and hypothesis-driven preclinical studies could help to identify the most promising candidates for clinical trials, and also offer new insights into the biological mechanisms that underlie drug synergies.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

About this article

Publication history





    Further reading Further reading

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing